Stock Track | Applied Digital Soars 5.02% as Company Completes Cloud Business Separation, Establishes Chronoscale as Independent Public Company

Stock Track05-06

Applied Digital Corporation's stock surged 5.02% during intraday trading on Tuesday, following the announcement of a significant corporate restructuring.

The company completed the separation of its cloud business, contributing it to EKSO Bionics Holdings, Inc., which has been renamed ChronoScale Corporation. As a result, ChronoScale began trading as an independent public company on the Nasdaq Capital Market under the ticker "CHRN." Applied Digital received approximately 138 million shares of ChronoScale common stock for the contribution and invested an additional $15.75 million in cash for about 1.4 million more shares, resulting in Applied Digital owning approximately 97% of ChronoScale's outstanding common stock post-transaction.

This strategic move is intended to allow Applied Digital to focus on its data center hosting platform, which operates on long-duration contracts, while enabling the newly formed ChronoScale to independently pursue growth in the cloud compute layer, particularly for demanding artificial intelligence workloads. The market reacted positively to this corporate simplification, which provides clearer business structures for both entities.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment